title: A common feature-based 3D-pharmacophore model generation and virtual screening: identification of potential PfDHFR inhibitors.
abstract: A four-feature 3D-pharmacophore model was built from a set of 24 compounds whose activities were reported against the V1/S strain of the Plasmodium falciparum dihydrofolate reductase (PfDHFR) enzyme. This is an enzyme harboring Asn51Ile + Cys59Arg + Ser108Asn + Ile164Leu mutations. The HipHop module of the Catalyst program was used to generate the model. Selection of the best model among the 10 hypotheses generated by HipHop was carried out based on rank and best-fit values or alignments of the training set compounds onto a particular hypothesis. The best model (hypo1) consisted of two H-bond donors, one hydrophobic aromatic, and one hydrophobic aliphatic features. Hypo1 was used as a query to virtually screen Maybridge2004 and NCI2000 databases. The hits obtained from the search were subsequently subjected to FlexX and Glide docking studies. Based on the binding scores and interactions in the active site of quadruple-mutant PfDHFR, a set of nine hits were identified as potential inhibitors.
authors.affiliation: National Institute of Pharmacuetical Education and Research, S.A.S. Nagar, Mohali, India.
authors.forename: Legesse
authors.initials: L
authors.lastname: Adane
authors.forename: Prasad V
authors.initials: PV
authors.lastname: Bharatam
authors.forename: Vikas
authors.initials: V
authors.lastname: Sharma
mesh_terms: D000962:Antimalarials / Q000737:chemistry* / Q000378:metabolism; D001185:Artificial Intelligence; D020134:Catalytic Domain; D016208:Databases, Factual; D055808:Drug Discovery; D004353:Drug Evaluation, Preclinical / Q000379:methods; D004351:Drug Resistance; D005493:Folic Acid Antagonists / Q000737:chemistry* / Q000378:metabolism; D006860:Hydrogen Bonding; D057927:Hydrophobic and Hydrophilic Interactions; D016778:Malaria, Falciparum / Q000188:drug therapy; D008958:Models, Molecular; D008968:Molecular Conformation; D050505:Mutant Proteins / Q000737:chemistry / Q000378:metabolism; D010963:Plasmodium falciparum / Q000187:drug effects / Q000201:enzymology* / Q000235:genetics; D011485:Protein Binding; D012984:Software; D013762:Tetrahydrofolate Dehydrogenase / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism
chemical_list: D000962:Antimalarials; D005493:Folic Acid Antagonists; D050505:Mutant Proteins; D013762:Tetrahydrofolate Dehydrogenase